Acropolis Investment Management, LLC Aurinia Pharmaceuticals Inc. Transaction History
Acropolis Investment Management, LLC
- $1.79 Billion
- Q2 2025
A detailed history of Acropolis Investment Management, LLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Acropolis Investment Management, LLC holds 28,525 shares of AUPH stock, worth $322,903. This represents 0.01% of its overall portfolio holdings.
Number of Shares
28,525Holding current value
$322,903% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding AUPH
# of Institutions
240Shares Held
65MCall Options Held
1.14MPut Options Held
825K-
Tang Capital Management LLC San Diego, CA10MShares$114 Million5.24% of portfolio
-
Black Rock Inc. New York, NY9.27MShares$105 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5MShares$56.6 Million0.61% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$44.9 Million3.03% of portfolio
-
State Street Corp Boston, MA2.85MShares$32.3 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $1.61B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...